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Patients with systemic lupus erythematosus (SLE) or SLE-overlap syndromes often 
produce autoantibodies directed to UlRNA-binding proteins.1 Previously, we isolated 
and characterized autoantigen-binding Ab fragments directed to the U1RNA- 
associated A protein (U1A) from several variable (V) gene combinatorial phage 
libraries.2 Although these libraries have proven to be very successful, heavy (VH) and 
light (Vl) chains are randomly combined during construction of such libraries. 
Because we were interested in the utilization of the original Vh/Vl pairings of the 
encoding auto antibodies, we developed a single cell culture system for B cells using 
mouse thymoma EL-4 B5 cells.3 In combination with a preselection via recombinant 
antigen and single cell sorting using fluorescence-activated cell sorting (FACS), we 
were able to enrich for autoantigen-specific B cells. Vh and Vl genes originating from 
single U1 A-specifîc B cells were cloned in a phage display vector for expression of 
single-chain variable fragments (scFv).
Human mononuclear cells were isolated from SLE patients and selected against 
UlA-coated plates or biotinylated U1A coated to streptavidin-coupled superparamag- 
netic microbeads (MACS). Adhering cells were collected from the plates via trypsin 
treatment or were directly used in the case of UlA-bound MACS (F ig u re  1). The 
selected lymphocytes were plated as single CD19/CD20-positive cells using FACS 
with an automatic cell deposit unit. Single selected B cells were seeded on 96-well 
plates containing 20,000 irradiated EL-4 B5 cells and 10% supernatant of phorbol 
myristate acetate (PMA)- and phytohemagglutinin (PHA)-activated human T cells 
(F ig u re  2). Cultures were grown for 10-11 days and tested in ELISA for antigen 
(Ag)-specific antibodies and total Ig production. Cell cultures that were positive in the 
Ag-specific ELISA screening were used for RNA isolation. An RT reaction was 
performed with an oligo-dT primer and the cDNA was used in a first PCR with VH 
family-specific primers or a mixture of V-kappa or V-lambda primers (in the case of 
the light chains) as in Marks et al.4 These first PCR products were used in a second
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PCR with nested joining-region primers to introduce the appropriate restriction sites 
for cloning into pHENIX.2
Typical percentages of Ig-positive cells determined by ELISA after 10-11 days of 
culturing on EL-4 B5 cells in the presence of 10% human T cell supernatant varied 
between 50% and 70%. The frequency of Ag-specific B cell clones varied between 1% 
and 2.5% as a percentage of Ig-positive wells. Assuming that the frequency of 
Ag-specilic cells in the periphery varies between 10“5 and 10-4, this would indicate 
an enrichment factor of 100-1000. Distributions of IgG> IgM, and IgG/IgM double-
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FIGU RE 1. Antigen selection on peripheral blood mononuclear cells. Human mononuclear 
cells were isolated from autoimmune patients (SLE) and used to select on UlA-coated plates or 
biotinylated U1A coated to streptavidin-coupled MACS. Selected cells were collected from the 
plates via trypsin treatment or were directly used in the case of U1 A-bound MACS. Magneti­
cally sorted cells (MACS) can be processed using FACS.
positive isotypes in Ig-producing single B cell cultures were 3:3:1, After culture in the 
EL-4 B5 system, the B cells obtained a plasmablast-like phenotype expressing 
CD38high and SYNDECAN-1M0D* (plasma cell marker). PCR products using cDNA 
from a single B cell clone amplified with separate VH family-specific primers and 
constant region primers (IgG- or IgM-specific) gave rise to only one Vh product, 
which indicates clonality. In the case of the light chains, a product with either V-kappa 
or V-lambda primers was obtained. Five IgM and 2 IgG anti-UI A-specific clones have 
been isolated. So far, we have sequenced only one clone with V regions derived from
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FIGURE 2. The selected lymphocytes were plated as single cells using FACS with an 
automatic cell deposit unit in 96-well plates containing 20,000 irradiated EL-4 B5 cells and 10% 
supernatant of phorbol myristate acetate (PMA)- and phytohemagglutinin (PHA)-activated 
human T cells. Cultures were grown for 30-11 days and tested in ELISA for Ag-specific 
antibodies and total Ig production.
DP-49 (Vh3) for the heavy chain and lv318 for the lambda light chain. We have been 
able to show binding of the cloned V regions to the U1A protein in ELISA. Further 
studies are currently being performed to isolate functional recombinant antibodies 
containing original Vh/Vl pairings.
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